Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease
Authors
Keywords
Alzheimer’s disease, Amyloid beta, Plaques, Intraneuronal amyloid, Microglia, Neuroinflammation
Journal
Molecular Neurodegeneration
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-01
DOI
10.1186/s13024-018-0244-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia in Alzheimer’s disease
- (2017) Heela Sarlus et al. JOURNAL OF CLINICAL INVESTIGATION
- Microglia emerge as central players in brain disease
- (2017) Michael W Salter et al. NATURE MEDICINE
- Structural differences between amyloid beta oligomers
- (2016) Leonid Breydo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology
- (2016) Elizabeth E. Spangenberg et al. BRAIN
- Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke
- (2016) Gergely Szalay et al. Nature Communications
- Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System
- (2015) Julia Bruttger et al. IMMUNITY
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
- (2014) Daniela Puzzo et al. BIOCHEMICAL PHARMACOLOGY
- Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates
- (2014) Marco Diociaiuti et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphismsin Vitroand in Alzheimer Disease Brain
- (2014) Asa Hatami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain
- (2014) Monica R.P. Elmore et al. NEURON
- Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival
- (2013) Jian Luo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
- (2013) William A Eimer et al. Molecular Neurodegeneration
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Disease: Critical Notes on the History of a Medical Concept
- (2012) Jesus Ramirez-Bermudez ARCHIVES OF MEDICAL RESEARCH
- Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Aβ oligomers
- (2011) Rakez Kayed et al. Molecular Neurodegeneration
- Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
- (2011) Stéphane P. Poulin et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Mechanism of amyloid plaque formation suggests an intracellular basis of A pathogenicity
- (2010) R. P. Friedrich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now